Author:
Gatell J M,SanMiguel J G,Araujo V,Zamora L,Maña J,Ferrer M,Bonet M,Bohe M,Jimenez de Anta M T
Abstract
Netilmicin or tobramycin was administered to 197 patients in a prospective randomized double-blind trial. Of these patients, 140 recipients of nine or more doses of netilmicin or tobramycin could be evaluated for nephrotoxicity. Fifty-five patients were able to cooperate in the administration of serial audiograms. Nephrotoxicity of similar severity developed in 7 of 73 (9.6%) recipients of tobramycin and in 7 of 67 (10.4%) recipients of netilmicin (P greater than 0.05). Mild or slight auditory toxicity developed in 5 of 28 (17.8%) recipients of tobramycin and in 2 of 27 (7.4%) recipients of netilmicin (P greater than 0.05).
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ototoxicity After Childhood Cancer;Late Treatment Effects and Cancer Survivor Care in the Young;2020-11-06
2. Aminoglycoside antibiotics;Meyler's Side Effects of Drugs;2016
3. Tobramycin;Meyler's Side Effects of Drugs;2016
4. Rational use of aminoglycosides—Review and recommendations by the Swedish Reference Group for Antibiotics (SRGA);Scandinavian Journal of Infectious Diseases;2012-12-28
5. Tobramycin for the treatment of bacterial pneumonia in children;Expert Opinion on Pharmacotherapy;2012-02